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The virulence of Gram-positive bacteria is enhanced
by toxins like the Streptococcus pyogenes b-NAD+
glycohydrolase known as SPN. SPN-producing
strains of S. pyogenes additionally express the
protein immunity factor for SPN (IFS), which forms
an inhibitory complex with SPN.We have determined
crystal structures of the SPN-IFS complex and IFS
alone, revealing that SPN is structurally related to
ADP-ribosyl transferases but lacks the canonical
binding site for protein substrates. SPN is instead
a highly efficient glycohydrolase with the potential
to deplete cellular levels of b-NAD+. The protective
effect of IFS involves an extensive interaction with
the SPN active site that blocks access to b-NAD+.
The conformation of IFS changes upon binding to
SPN, with repacking of an extended C-terminal
a helix into a compact shape. IFS is an attractive
target for the development of novel bacteriocidal
compounds functioning by blocking the bacterium’s
self-immunity to the SPN toxin.
INTRODUCTION
The virulence of many bacteria is enhanced by powerful toxins
that are injected into host cells where they co-opt cellular physio-
logy by modulating signaling pathways, reorganizing the cyto-
skeleton, causing programmed cell death, or changing cellular
metabolism (Bhavsar et al., 2007). The Gram-positive bacterium
Streptococcus pyogenes causes a variety of human diseases
ranging from superficial and self-limiting infections (pharyngitis,
impetigo) to conditions that are highly destructive to tissue and
life threatening (necrotizing faciitis), including those caused by
dysregulation of the immune system (rheumatic fever, acute
glomerulonephritis) (Cunningham, 2000). Group A Strepto-
coccus spp. encode a pore-forming protein Streptolysin
O (SLO) that functions as a conduit to inject the toxin SPN192 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All r(S. pyogenes b-NAD+ glycohydrolase) into the host cell. Once
inside the host cell, SPN alters cellular functions and induces
a cytotoxic response that ultimately causes cell death (Bricker
et al., 2002; Madden et al., 2001).
Themechanism bywhich SPN alters host cell physiology is not
understood, although the purified recombinant enzyme has
robust b-NAD+-glycohydrolase (GHase) activity and appears
to lack activity as an ADP-ribosyl transferase (RTase) or
a ADP-ribosyl cyclase (ACase) (Ghosh et al., 2010), despite
earlier reports of these activities in cell extracts from SPN-
producing strains (Grushoff et al., 1975; Karasawa et al., 1995;
Stevens et al., 2000). GHase activity converts b-NAD+ to nicotin-
amide and ADP-ribose (ADPR) and has the potential to deplete
cellular stores of the essential cofactor and signaling molecule,
b-NAD+ (Michos et al., 2006). Purified RTase enzymes typically
show low levels of GHase activity in the absence of a protein
substrate, whereas SPN has robust GHase activity (Ghosh
et al., 2010), in agreement with other prokaryotic enzymes
known as pure glycohydrolases (Everse et al., 1975a; Mather
and Knight, 1969).
The SPN protein consists of two domains. The N-terminal
domain (residues 41–190) is required for secretion of SPN
through the SLO pore (Ghosh and Caparon, 2006). The
C-terminal domain (residues 191–451) contains the active site,
and its GHase activity in vitro is comparable to full-length SPN
(Ghosh and Caparon, 2006). Although SPN is a pure GHase,
the C-terminal domain contains amino acid sequence motifs
that are hallmarks of multifunctional ACases (Ghosh and Capa-
ron, 2006) and RTases (see below), raising questions about the
origins of selective GHase activity. The N-terminal domain of
SPN is not conserved in ACases andRTases and has a predicted
jelly-roll fold, similar to those of glycan-binding proteins (Ghosh
and Caparon, 2006).
The SPN GHase is highly toxic when expressed in Escherichia
coli and presumably depletes cellular stores of b-NAD+. In
S. pyogenes, SPN is expressed in a complex with the immunity
factor for SPN (IFS) that functions as an antitoxin by blocking
SPN enzymatic activity as a competitive inhibitor of b-NAD+
(Kimoto et al., 2006; Meehl et al., 2005). IFS lacks a signal
sequence and is located exclusively in the cytoplasm of S. pyo-
genes, so the protective effect of IFS likely results from inhibitingights reserved
Figure 1. Domain and Three-Dimensional Structure of the SPNct-IFS Complex
(A) Orthogonal views of the SPNct-IFS complex that was crystallized, depicted as ribbon structures. The orientation of SPNct in the left panel matches that of (C),
and the IFS orientation in the right panel corresponds to the orientation in (D). Full-length SPN (451 amino acids) consists of three regions: a secretion signal (black)
that is cleaved during secretion, a translocation domain (green), and a glycohydrolase domain (yellow). The IFS protein (161 residues) is not secreted when SPN is
injected into the host cell.
(B) A close-up view of SPNct showing secondary structural elements and the ADase signature motifs. The N-terminal linker region (red) between the catalytic
domain and secretory domain of SPN (not present in the crystal structure) is a unique adaptation of SPN’s RTase-like fold. The conserved ARTT motif (green),
STS motif (purple), and Arg/His motif (orange) of the RTase superfamily are present in SPNct.
(C) A close-up view of IFS highlighting the SPN-interacting loops, SIL1 and SIL2 (cyan).
(D) Stereo diagram of the SPN active site with superimposed NAD+ docking models corresponding to different binding modes seen in structures of CTx (white),
DTx (grey), and iota toxin (black). SPN residues that are in hydrogen-bonding distance are highlighted in blue, and conserved residues found in the ARTT motif
(green), STS motif (purple), and Arg/His (orange) are shown.
See also Figures S1 and S2.
Structure
Structure of S. pyogenes IFS and SPNGHase activity of presecretory SPN pools that fail to be exported
from the bacterium (Kimoto et al., 2006; Meehl et al., 2005). The
biological importance of SPN immunity is illustrated by the fact
that the gene for IFS is absolutely essential for the viability of
SPN-producing S. pyogenes strains (Meehl et al., 2005) and for
overexpression of SPN in a heterologous host like E. coli (Kimoto
et al., 2006; Meehl et al., 2005).
To understand the physical basis for SPN’s enzymatic activi-
ties and its inhibition by IFS, we determined the crystal structure
of the catalytically active SPNct domain complexed to IFS (Fig-
ure 1). Our analysis reveals that the protein fold of SPN is remark-
ably similar to canonical RTases like cholera toxin and diphtheria
toxin, including several conserved sequence motifs in the active
site (Figure 2). However, structural variations in SPN can explain
its failure to ADP-glycosylate protein substrates (Figure 3) while
retaining robust glycohydrolase activity. The structure of the
SPN-IFS complex reveals how IFS inhibits SPN enzymaticStructure 19, 19activity by binding over the active site and completely blocking
access to b-NAD+ (Figures 1 and 4). The structure of IFS
determined in the absence of SPN reveals an alternative confor-
mation of a C-terminal a-helical domain that is incompatible with
binding to SPN (Figure 5). The conformational switch required for
IFS to bind to SPN could be exploited by developing novel
antimicrobials that block immunity of group A Streptococci to
SPN and cause toxicity in SPN-producing strains.
RESULTS
Overall Structure of the SPNct-IFS Complex
The full-length, mature SPN protein (residues 38–451)
in complex with IFS (161 amino acids) did not crystallize, so
a C-terminal enzymatically active domain of SPN (SPNct; resi-
dues 191–451) was identified by limited proteolysis, and overex-
pressed in E. coli as a recombinant protein in complex with IFS.2–202, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 193
Figure 2. SPNct Has a RTase-like Fold
(A) Structural alignment of SPNct with ribosyltransferases: diphtheria toxin (1 dtp), cholera toxin (2a5f), C3bot (1gzf), C3tau (1ojz), and Vip2 (1qs2). In the left panel,
SPNct is shown in blue (RTase domain) and red (helical linker), with the other RTases shown in gray. The helical linker of SPNct is not present in other RTase super-
family enzymes. Conserved active residues of the DTx (center) and CTx/C3 (right) families of RTases are present in SPNct. SPNct residues corresponding to the
ARTT motif (green), the Arg/His motif (orange), and STS motif (purple) are shown as sticks (cf. Figure 1C).
(B) Aligned sequences of RTase motifs colored according to the scheme in (A).
Structure
Structure of S. pyogenes IFS and SPNThe deleted N-terminal CMT domain (residues 1–190) is pre-
dicted to have a b strand structure (Rost et al., 2004), and the
ProDom database (Servant et al., 2002) predicts a ‘‘jelly-roll’’
fold for this region. Although the N-terminal CMT domain is
required for translocation of SPN into host cells and biological
activity (Ghosh and Caparon, 2006), it has no significant effect
on enzymatic activity in vitro (Ghosh and Caparon, 2006). The
SPNct-IFS complex produced well-diffracting crystals (Figure 1A
and Table 1; see Figure S2 available online), and the structure
was determined at 2.8 A˚ resolution using phasing information
from a selenomethionyl-labeled derivative by a multiple wave-
length anomalous diffraction X-ray experiment (Table 1).
The SPNct domain has a mixed a/b fold (Figure 1B), with
a shape reminiscent of an open bowl. IFS serves as a lid covering
the active site pocket of SPN (Figure 1A). The active site motifs
and core b sheet structure of the RTase family are conserved
in the SPNct protein (Figure 3), as described inmore detail below.
The core structure of IFS comprises a single domain of eight
helices that are connected by several extended loops (Fig-
ure 1C). Two of these loops make intimate contacts with SPNct,
and we have named them the SPN Interaction Loops, SIL1 (resi-
dues 29–50) and SIL2 (residues 137–150; Figures 1C and 5). SIL1
is preserved as a loop in the bound and free conformations of
IFS, whereas SIL2 rearranges in the unbound form of IFS and
is incorporated into a continuous helix projecting from the
protein core (Figure 5A). This extended helix is incompatible
with the binding interactions seen in the SPNct-IFS complex.
SPNct Is Structurally Homologous
to Ribosyltransferases
We compared the structure of SPNct with those of related
b-NAD+-dependent enzymes. There are no structures of strict
GHases in the Protein Data Bank, and the amino acid sequence194 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All rof SPN has limited homology with other proteins, except for SPN
orthologs from other Streptococcus spp. (e.g., Kimoto et al.,
2005). The SPN sequence and structure are unrelated to those
of multifunctional GHase/ACases, including human CD38 and
a GHase/ACase from Aplysia californica (Love et al., 2004),
which contain multiple disulfide bonds that stabilize the protein
fold. Furthermore, the eukaryotic GHase/ACases are homo-
dimers, whereas SPNct is a monomer (Meehl et al., 2005). Based
on these criteria, we determined that SPNct is not structurally
homologous to these enzymes.
However, the SPNct structure superimposes well onto several
different RTases, including two universally conserved motifs in
the active site (Figure 3). Although the sequences of bacterial
RTases are divergent, these proteins share a conserved core
structure consisting of seven b strands arranged in two perpen-
dicular b sheets that bracket the b-NAD+ binding pocket (Han
and Tainer, 2002). This core b sheet sandwich is decorated
with different configurations of helices, forming a variety of mixed
a/b structures in various RTase family members. A helix or a vari-
able-sized loop lies on one side of the b-NAD+ binding pocket in
various RTase family members and is hypothesized to be impor-
tant for substrate recognition (Han et al., 2001). A structure-
based alignment of the SPN amino acid sequence with several
structurally homologous RTases did not reveal this element, or
any significant sequence homology outside of a few active site
motifs described below.
All RTases harbor an ADP-ribosyl-turn-turn (ARTT) motif in
their active site, which includes a catalytically essential glutamic
acid (Holbourn et al., 2006). SPN’s ARTT motif features Glu391,
which is required for enzymatic activity in vitro (Ghosh et al.,
2010). A second highly conserved residue of the ARTT motif is
a glutamic acid or glutamine (SPN Glu389) located two residues
N terminal to the essential catalytic glutamic acid. Theights reserved
Figure 3. The Binding Site for Protein Substrates of Other RTases Is Occluded in SPNct
(A) The structures of SPNct and the RTase SpvB (2gwl) were superimposed onto the structure of C3iota in complex with its actin substrate (3buz; left panel) (Tsuge
et al., 2008). The b-NAD+ mimic TAD (b-methylene-thiazole-4-carboxamide adenine dinucleotide; gray) identifies the active site of C3iota in the complex. The
helical linker of SPNct (red) clashes with the docked actin protein (middle panel), suggesting that SPN does not accommodate protein substrates in the canonical
mode of other RTases. The docking model for SpvB readily accommodates actin, which is a known substrate for ADP ribosylation by this enzyme.
(B) In a similar manner as in (A), the structures of SPNct and DTx were superimposed onto the RTase ETA in complex with its substrate eEF2. The left panel is the
crystal structure of ETA-eEF2 complex (Jorgensen et al., 2005). The model of SPNct docked against eEF2 reveals a clash with the helical linker of SPNct (red). In
contrast the docking model for DTx does not show significant clashes with eEF2, a substrate for ADP ribosylation by DTx.
Structure
Structure of S. pyogenes IFS and SPNconformation of SPN’s ARTT loop is different from other RTase
proteins because of packing interactions involving SPN’s unique
a-helical linker subdomain (Figure 1D). Nonetheless, ARTT
residues Glu389 and Glu391 in SPN superimpose well with the
analogous residues of other RTases (Figure 3A). The presence
of a typical ARTT motif in the SPN active site is additional
evidence for SPN’s inclusion as a member of the RTase super-
family. However, the high level of sequence divergence between
SPN other RTases suggests that SPN represents an atypical
member of the superfamily.
Another universal feature of RTase active sites is the R/Hmotif,
consisting of an arginine or histidine preceded by two hydro-
phobic residues, which are typically an aliphatic residue followed
by an aromatic residue. These residues support binding to
b-NAD+ and/or maintaining the structure of the active site (Hol-
bourn et al., 2006). The signature histidine (His273) (Figure 2A,
middle and right panels) of SPN’s R/Hmotif is located on b strand
1, although His273 is preceded by an alanine (Ala271) and serine
(Ser272) instead of the aliphatic/aromatic residue pair that is
typical of a canonical R/Hmotif (Figure 2B). It remains to bedeter-
mined if His273 contributes to the enzymatic activity of SPN.
Atypical b-NAD+ Binding Pocket
The Diphtheria Toxins (DTx) and Cholera Toxins (CTx) constitute
two large families within the RTase superfamily that are distin-
guished by different motifs within the b-NAD+ binding pocket
and active site. The DTx family is defined by a Y-X10-Y motif,Structure 19, 19consisting of a pair of tyrosines separated by a ten residue
spacer that stack against the aromatic nicotinamide ring of
b-NAD+ (Domenighini and Rappuoli, 1996). In the CTx family
the Y-X10-Y motif is replaced by a Ser-Thr-Ser (STS) motif in
an analogous location, and CTx family members have either an
‘‘active site loop’’ or an ‘‘a3 helix’’ that participates in binding
to polypeptide substrates (Holbourn et al., 2006). The STS and
Y-X10-Y motifs of the CTx and DTx proteins, respectively, are
located in the vicinity of strand b2 on the core b sheet structure
of the RTase superfamily (Figure 1B).
The SPNct active site lacks the Y-X10-Y (data not shown) and
STS motifs (Figure 2A), and there is no obvious ‘‘active site
loop’’ or the ‘‘a3 helix’’ found in CTx-type enzymes. Consistent
with its role as a pure GHase, SPN lacks these protein
substrate-binding motifs, although other RTase signature resi-
dues are present in the active site. The NAD+ cofactor binds in
slightly different orientations within the active sites of RTases
crystallized in complex with NAD+. A docking model based on
superposition of these structures onto SPNct suggests that
SPN’s active site can easily accommodate NAD+, with several
residues in hydrogen-binding distance of the modeled NAD+
ligand. Arg295 is positioned for hydrogen bonding to the adenine
phosphate of b-NAD+. Lys335 is also in close proximity and
could potentially hydrogen bond to the ribose oxygen of adenine.
Arg289 lies close to the amino group of the adenine base. The
NAD+-binding pocket is capped by IFS, which appears to
prevent binding.2–202, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 195
Figure 4. Polar Interactions Stabilize the
SPNct-IFS Complex
(A) SIL1 inserts into the active site pocket of SPN
and makes numerous hydrogen-bonding and
electrostatic interactions.
(B) SIL2 makes hydrogen-bonding interactions on
the rim that forms part to the active site of SPN.
Structure
Structure of S. pyogenes IFS and SPNSPNct Modeled with Known RTase Protein Substrates
Purified SPN does not exhibit RTase activity (Ghosh et al., 2010),
and we superimposed the structure onto various RTase-protein
complexes to examine if SPN could potentially bind to protein
substrates. The RTase-substrate complexes show different
extents and modes of interacting with proteins targeted for
ADP ribosylation (Figure 3), yet the amino acid side chain
targeted for ADP ribosylation is positioned similarly in the
b-NAD+ binding pocket, and the protein substrate binds on the
same aspect of the conserved RTase fold. However, our
substrate docking models reveal a clash with the a-helical
subdomain that joins the SPN catalytic domain to an N-terminal
domain (Figure 3, in red). The SPN interdomain linker occludes
the usual substrate-binding site present in the RTases, as shown
by two examples in Figure 3. In one example we superimposed
the crystal structure of the CTx family member Clostridium
botulinum C3iota in complex with its G-actin substrate (Tsuge
et al., 2008) onto the SPNct structure (Figure 3A). C3iota binds
to G-actin in a different orientation than that of the ETA-eEF2
complex, but the superimposed SPNct structure still clashes
with G-actin in the docking model (Figure 3A, center panel).
Specifically, the ARTT loop and helices a1–a3 of SPN’s linker
subdomain both clash with G-actin. Notably, the G-actin residue
Arg177 targeted for ADP ribosylation by C3iota poses a severe
clash with SPNct residues Trp380 and Leu372. The Salmonella
enterica SpvB protein is a RTase that posttranslationally
modifies G-actin, and superposition of SpvB onto C3iota com-
plexed to G-actin shows a good fit of actin in the docking model
(Figure 3A, right panel). We conclude that SPN cannot bind to
a protein substrate in the same mode as these RTases without
a rearrangement of SPN’s a-helical linker subdomain.
In a second example of RTase-substrate interactions, the
crystal structure of Pseudomonas aeruginosa enterotoxin196 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All rights reservedA (ETA, a DTx family member) complexed
with the protein substrate eEF2 (Jorgen-
sen et al., 2005) was superimposed onto
SPNct. Helix a2 within SPNct’s linker
subdomain (Figure 1B) severely clashes
with the docked eEF2 substrate (Fig-
ure 3B, center panel), and additional
clashes are observed with SPN’s ARTT
loop and helix a5. In contrast to SPN
the structure of the Corynebacterium
diphtheriaeDTx protein, which posttrans-
lationally modifies the eEF2 protein, is
well accommodated by a docking model
based on the DTx-eEF2 complex (Fig-
ure 3B, right panel). These docking
studies reveal that SPN is unable to
accommodate protein substrates in themodes utilized by other RTases, supporting the conclusion that
SPN’s catalytic activity is limited to GHase activity despite
having many features of a RTase toxin.
The presence of the linker subdomain also increases the depth
of SPN’s b-NAD+ binding pocket in comparison to the bona fide
RTase proteins, which could further interfere with activity toward
protein substrates. In fact the IFS subunit in the SPNct-IFS
complex structure does not directly contact the catalytic resi-
dues of the SPN active site. SPN’s a-helical linker also contrib-
utes interactions with IFS, supporting immunity to SPN-based
toxicity. This protective function may be a strong evolutionary
driver for maintaining the linker as a protein-interaction surface
that gives SPN a unique structural identity among RTase family
proteins.
Structure of the IFS Inhibitory Factor
In the complex with SPNct, the protein fold of IFS is a compact
helical bundle with a loosely structured N-terminal region.
Helices a4–a6 constitute the core of the protein, which is deco-
rated by helices a1–a3. In the N-terminal region of IFS, the
22 residue SIL1 loop connects helices a2 and a3, and a ten
residue loop connects helices a5 and a6; both loops pack
against helices a3 and a4. At the C-terminal end of IFS, helices
a7a and a7b are joined together by SIL2 and pack against the
core of the protein. Helix a7amakes hydrophobic and polar inter-
actions with the helical head domain, whereas helix a7b makes
hydrophobic interactions with the hydrophobic patch created
from helices a5 and a6.
Structural homology searches using SSM (Krissinel and
Henrick, 2004) and DALI (Holm and Sander, 1996) reveal similar-
ities between IFS and several other a-helical proteins sharing
5%–12% sequence identity, including the ubiquitin addition
domain of RanGAP1 (Hillig et al., 1999) and VHS domain of
Figure 5. IFS Changes Conformation in Complex with SPN
(A) The unbound IFS structure (left panel) shows an extended conformation of the C-terminal region (blue), whereas this region adopts a compact structure (cyan,
right panel) in IFS bound to SPN (cf. Figure 1B).
(B) Hydrophobic residues (red) that are exposed in unbound IFS (left panel) become buried in the fold of bound IFS (right panel). Refolding of theC terminus breaks
helix a7 into two helical segments: a7a and a7b.
(C) The N-terminal region of IFS is flexible and adopts different conformations in the free and bound structures.
(D) A network of hydrogen bonds stabilizes the structure of the SIL1 loop in free and bound structures of IFS (see text for details).
Structure
Structure of S. pyogenes IFS and SPNADP-ribosylating factor (ADF) interaction proteins (Boman et al.,
2002; Mullins and Bonifacino, 2001; Shiba et al., 2002, 2003; Zhu
et al., 2003). However, these similarities are limited and appear to
be fortuitous—the functional surfaces of IFS contacting SPN are
not conservedwith these other proteins, which function as adap-
tors that bind to signaling and vesicular proteins. These findings
suggest that these proteins are functionally unrelated, although
they are likely to have evolved from a common ancestral fold.
Interactions between SPNct and IFS
The extensive interaction between SPNct and IFS buries more
than 3200 A˚2 of protein surface area, forming a seal around the
entire rim of SPNct’s concave active site (Figure 1A). IFS does
not directly contact the catalytic residues in SPN’s active site
but instead blocks access to b-NAD+ by covering over the active
site pocket. Numerous hydrogen bonds and electrostatic inter-
actions secure the complex between SPNct and IFS, which
features a striking complementarity of electrostatic potential.
The surface of IFS is predominately negatively charged, whereas
the opposing surface of SPNct is positively charged (Figure S1).
Charge-charge interactions are likely to contribute to the long-
lived complex with IFS that effectively blocks SPN enzymatic
activity. In the absence of IFS, this hydrophilic surface of SPNct
would be exposed to solvent and could mediate interactions
with substrates.Structure 19, 19IFS contacts SPN mainly through two extended loops, SIL1
and SIL2 (Figure 1C). SIL1 is a highly convoluted loop connecting
helices a2 and a3 of IFS. The beginning of the SIL1 loop (residues
29–38) contacts another small loop located between the first two
helices of SPNct (Figure 4A). Lys33 of IFS is within hydrogen-
bonding distance of the carbonyl oxygens of Glu206 and
Lys208 in the SPN protein. Thr38 makes water-mediated inter-
actions with SPN Asp209 and Trp211 (Figure 4A). The middle
of SIL1 is poised over the b-NAD+ binding pocket where IFS resi-
dues 39–43 make electrostatic and hydrogen-bonding interac-
tions with SPN residues on either side of the pocket. Arg39 forms
a salt bridge with Asp279 (Figure 4A). Arg40 forms a hydrogen
bond with the carbonyl of Gly330 and Trp380. Asp41 makes
an electrostatic interaction with Lys335. The carbonyls of
Ser42 and Tyr43 are within hydrogen-bonding distance of the
N3 atom of Arg295 in SPNct (Figure 4A). The last section of the
SIL1 (residues 44–50) winds around the back of the b-NAD+
binding pocket and makes its interactions with loop between
the b2 strand and a6 helix (residues 285–300) of SPNct. The
amide of Gly45 of IFS makes a water-mediated hydrogen-
bonding interaction with the carbonyl oxygen of Ala369 and
the amide nitrogen of Gly368 (Figure 4A).
The SIL2 loop, located between helices a7a and a7b, is
a secondmajor region of IFS interaction with SPN. SIL2 contacts
two loops on the rimof SPN’s b-NAD+binding pocket (Figure 4B),2–202, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 197
Table 1. Crystallographic Data and Model Refinement Statistics
Crystal
SPN/IFS IFS
Peak Inflection Remote Peak Inflection Remote
Resolution (A˚) 42.72–2.8
(2.90–2.80)a
42.64–2.8
(2.90–2.80)
42.72–2.8
(2.90–2.80)
46.8–2.5
(2.59–2.5)
46.8–2.5
(2.59–2.5)
46.8–2.5
(2.59–2.5)
l 0.97892 0.97938 0.99510 0.97901 0.97932 0.99504
Mosaicity 0.86 0.83 0.86 0.43 0.42 0.41
Total measurements 181,424 181,118 182,378 470,532 471,606 547,619
Unique measurements 46,783 46,736 46,783 66,240 66,415 66,456
Redundancy 3.88 (3.83) 3.88 (3.84) 3.88 (3.83) 7.1 (7.05) 7.1 (7.07) 8.24 (8.15)
Completeness (%) 100 (100) 100 (100) 100 (100) 100 (100) 100 (100) 100 (100)
<I/sI > 9.2 (2.6) 7.2 (2.2) 10.4 (3.4) 12.6 (3.3) 12.8 (3.0) 14.3 (4.3)
Rsym 0.079 (0.328) 0.091 (0.391) 0.069 (0.265) 0.077 (0.427) 0.077 (0.457) 0.069 (0.363)
MAD phasing
Resolution (A˚) 41.7–2.8 41.7–2.8 46.8–2.5 46.8–2.5
Number of sites 26 26 26 26
Phasing power (anom) 1.05 (1.02) 0.92 (0.64) 1.25 (1.24) 2.07 (1.22)
Rcullis (anom) 0.70 (0.83) 0.73 (0.91) 0.56 (0.71) 0.51 (0.72)
Overall FOM 0.286 0.301
Refinement statistics
Number of reflections
Working set 23,069 32,775
Test set 1,240 1,739
Rwork 0.212 0.259
Rfree 0.287 0.289
Rmsd bond length 0.010 0.0071
Rmsd bond angles 1.193 1.109
a Values in parentheses are for the highest resolution shell.
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Structure of S. pyogenes IFS and SPNone that is located between the SPNct b4 strand and ARTT loop
(see below; residues 361–380) and the other between the a6
helix and b2 strand (residues 285–300). In a manner analogous
to Gly45 of SIL1, the SIL2 residueGlu142makeswater-mediated
hydrogen-bonding interactions with the carbonyl oxygens of
Ala369 and amide of Gly368 (Figure 4B). The amide nitrogen of
Asp148 makes water-mediated interactions with Gln296 and
Glu297, whereas the Asp148 side chain makes interactions
with Gln296 (Figure 4B). Auxiliary interactions in this region occur
through helix a7b of IFS. Arg156 makes interactions with the
carbonyl of Ala 287, and Thr157 makes a water-mediated
hydrogen bond with Asp286 (Figure 4B). This network of polar
interactions between IFS and SPNct is suggestive of a stable
protein complex. However, the hydrophilic character of this
interface is also consistent with SPN’s stand-alone role as
a soluble toxin that is injected into the host cytosol.
Structural Dynamics of IFS
The crystal structure of IFS in the absence of SPN reveals
a different conformation of the C-terminal helices a7a and a7b
(Figure 5), which in the absence of SPN, fold into a continuous
a helix (a7) that projects from the core of the IFS protein and
resembles the letter ‘‘P’’ (Figure 5A). This rearrangement elimi-
nates the SIL2-interaction loop (Table 1 and Figure 5B) and
presumably is inactive for binding to SPN. It is likely that this
extended conformation of IFS is energetically favorable and198 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All rpopulated in solution. Four crystallographically independent
molecules of IFS exhibit the same extended conformation of
helix a7, despite different crystal-packing environments (data
not shown). These IFS molecules differ only in the number of
disordered residues at their C termini; the ordered region of
monomer A spans residues 1–156, monomer B spans residues
1–173, monomer C spans residue 1–164, and monomer D
1–159. The elongated shape of unliganded IFS is also consistent
with its anomalous behavior on gel filtration and large apparent
molecular mass (31,500 Da including the c-Myc tag and His6
affinity tag, versus the calculated molecular mass of 21,960
Da) that was estimated by dynamic light scattering. Furthermore,
deuterium exchange studies of IFS support the conclusion that
the C-terminal residues spanning helix a7 are exposed and freely
exchangeable in the unbound state (J. Sperry and M. Gross,
personal communication).
The core structure of IFS spanning helices a1–a6 is
unchanged in bound and free forms of IFS, except for localized
rearrangements in three regions of interaction with SPNct. The
transformation of a7 buries 200 A˚ of hydrophobic surface
area that is exposed on the surface of a5 and a6 in the unbound
IFS conformation (involving C-terminal residues Leu151, Val154,
Ile158, and Tyr161) (shown in red in Figure 5B).
N-terminal residues 1–9 are in an extended conformation in
the uncomplexed IFS, and when bound to SPNct, the protein
backbone is twisted by two rotations of approximately 180ights reserved
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Structure of S. pyogenes IFS and SPN(Figure 5C). This twisted conformation is further stabilized by the
side chain of IFS Gln12, which donates a bifurcated hydrogen
bond to the main chain carbonyl oxygens of Pro5 and Gly7 (Fig-
ure 5C). This change upon binding to SPNct redirects the poly-
peptide chain of IFS and extends the surface of contact with
SPNct.
The conformation of the SIL1 loop changes significantly in the
bound and unbound structures of IFS. The conformation of SIL1
in the SPN-IFS complex is established by a series of internal
hydrogen bonds, including a hydrogen bond between Lys26
and Asp32 within the beginning of the loop (Figure 5D, right
panel). Arg36 interacts with the carbonyls of Gly30 and Ser31,
whereas Ser48 hydrogen bonds to the carbonyl of Tyr35 and
the amide of Ile37. The middle of the SIL1 loop is conformation-
ally constrained by two hydrogen bonds from Ser42 to the main
chain amide of Arg39 and the side chain of Asp49. The
C-terminal end of SIL1 interacts with SIL2 via several hydrogen
bonds involving SIL1 residues Asp46 andGly45 andSIL2 residue
Glu142. In the unbound IFS structure, themiddle of the SIL1 loop
moves closer to helix a7, requiring Ser42 to forego its interaction
with Arg39. This apparent increase in the flexibility of SIL1 is
consistent with an absence of electron density for the Ser42
side chain in two of the four crystallographically independent
molecules of unbound IFS.
DISCUSSION
SPN and IFS constitute a protein complex that enhances bacte-
rial virulence while preventing self-destruction of the pathogen.
Similar toxin-antitoxin pairs have a wide phylogenetic distribu-
tion and include staphylococcal proteases and their endogenous
inhibitors (Potempa et al., 2005), toxin-antitoxins that ensure
carriage of plasmids (Hayes, 2003), and the chromosomally en-
coded toxin-antitoxin pairs that modulate growth of prokaryotes
in response to nutritional stress (Gerdes et al., 2005). Because
these antitoxins typically block toxins affecting bacterial cell
growth or viability, chemical inhibitors of antitoxin function could
prove useful as antimicrobials. Inhibitor development would
benefit from structural information about the antitoxin and its
mode of binding to the toxin, and knowledge of the mechanism
of toxin activity and its blockade by the antitoxin.
SPN is an atypical RTase with the conserved protein fold and
active site ARTT motif of the RTase superfamily, including the
catalytic residue Glu391 (Ghosh et al., 2010) (Figure 3). However,
SPNct does not accommodate protein substrates for ADP
ribosylation and lacks the Y-X10-Y and STS motifs contributing
to substrate interactions by diphtheria toxin and cholera toxin
family proteins, respectively (Holbourn et al., 2006). A unique
a-helical linker in SPNct (Figure 1) creates a clash with protein
substrates docked onto SPNct in the orientation of other
RTase-substrate complexes (Figure 4). The linker contributes
interactions with IFS (Figure 4A), whichmay explain the selection
for this feature of SPN. SPN is an efficient GHase in vitro and
causes a significant depletion of b-NAD+ stores in epithelial cells
exposed to SPN-producing strains of S. pyogenes or in yeast ex-
pressing recombinant SPN (Michos et al., 2006). These findings
indicate that SPN’s biological function(s) as a virulence factor is
significantly coupled with GHase activity, depleting b-NAD+
stores instead of modifying proteins through ADP ribosylation.Structure 19, 19The RTase-type fold of the SPN protein may have evolved to
catalyze efficient GHase activity through two types of genetic
alterations. The first alteration may have been the addition of
the a-helical linker region to couple SPN’s catalytic activity to
its cellular import mediated by SPN’s N-terminal domain. This
architectural addition would have the secondary consequence
of interfering with binding of protein substrates to SPN, therefore
limiting enzymatic activity to the reaction of b-NAD+ with water.
Subsequent modifications of the SPN active site may have
occurred by positive selection to increase the catalytic efficiency
of theGHase reaction in order to enhance bacterial virulence and
provide a growth advantage. Mutations in other RTase enzymes
have been reported to change relative rates of RTase andGHase
activities; however, the mutations that strongly suppress RTase
activity typically cause a concomitant reduction inGHase activity
(Holbourn et al., 2006). Thus, understanding the mechanistic
basis for selective b-NAD+ hydrolysis in the absence of ADP-ri-
bosylating activity would benefit from comparative structural
analyses of dedicated bacterial GHases. Several instances of
bacterial GHase activity have been reported (Davis, 1980; Everse
et al., 1975b; Mather and Knight, 1969), but the genes encoding
these enzymes have not been isolated, and their enzymatic
activities remain to be characterized.
Some clues about residues contributing to efficient GHase
activity have come from clinical isolates of S. pyogenes collected
during the past 20 years. Recent isolates express SPN proteins
with higher specific activity than strains isolated prior to 1989
(Tatsuno et al., 2007). Reduced GHase activity is associated
with a polymorphism at SPN residue 330 in which an aspartic
acid replaces the glycine found in the native enzyme (Tatsuno
et al., 2007). Residue 330 lies near the surface of the b-NAD+
binding pocket (Figure 4A) where the larger size and negative
charge of the aspartic acid may inhibit access of b-NAD+ to the
binding pocket. It seems unlikely that the high-activity Gly330
allele evolved from the lower-activity Asp330 allele, which is
consistently found in association with a nonfunctional, truncated
IFSallele suggestive of a lack of selection for IFSactivitywhen the
SPNAsp330 variant is present (Meehl et al., 2005). Thus, it seems
more likely that the high-activity Gly330 allele is ancestral to the
low-activity Asp330 allele, which consequently relieved selective
pressure for maintaining a functional IFS.
Bacterial expression of a GHase toxin requires coexpression
of a cognate antitoxin like IFS to prevent depletion of b-NAD+
(Everse et al., 1975a; Davis, 1980; Mather and Knight, 1969).
The occurrence of toxin-antitoxin pairs may argue for a different
evolutionary model in which the GHase enzymes are progenitors
of RTases and evolve by first decreasing GHase activity to elim-
inate the need for the protein inhibitor before acquiring efficient
RTase activity through additional mutational drift. The extant
bacterial RTases are expressed without a cognate inhibitory
protein, and their enzymatic activity is contingent upon interac-
tion with protein substrates in host cells that are either absent
from the bacterium or not essential for bacterial growth. The
transition from GHase to RTase activity could have occurred
by adaptations that changed the binding site for a protein inhib-
itor of the GHase to a site that binds the protein substrate of
a RTase.
A structural analysis of the interaction between SPN and IFS is
informative in this regard. The crystal structure of the SPNct-IFS2–202, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 199
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Structure of S. pyogenes IFS and SPNcomplex reveals that IFS binds to SPNct in a 1:1 complex and
that the SIL1 loopwould sterically clashwith b-NAD+ in the active
site, providing the molecular basis for the known ability of IFS to
act as a competitive inhibitor of b-NAD+ (Meehl and Caparon,
2004). It is noteworthy that a second IFS-binding site has been
described corresponding to SPN residues 38–166 (Tatsuno
et al., 2007), which are not present in the SPNct protein (residues
191–451) that was crystallized in complex with IFS. However,
because this site is not required to suppress the toxic effects
of SPNct in vivo (Ghosh and Caparon, 2006), its biological signif-
icance is uncertain.
A comparison of IFS structures, alone and in complex with
SPNct, reveals features that could be exploited for the develop-
ment of small molecule inhibitors of IFS that block interaction
with SPN, unleashing its auto-toxic activity against S. pyogenes.
The a-helical head domain of unbound IFS is appended by an
elongated C-terminal helix extending away from the head
domain. Consistent with the conformational flexibility revealed
in the crystal structure, the C-terminal region of purified IFS is
susceptible to proteolysis, and deuterium isotope exchange
studies reveal high rates of exchange in this region relative
to the head domain (J. Sperry and M. Gross, personal communi-
cation). In order to bind to SPNct, IFS must undergo extensive
conformational changes, including an adjustment of the
N-terminal SIL1loop, and the repacking of residues from the
C-terminal helix a7 to form two helices (a7a, a7b) (Figure 1C)
interrupted by the SIL2 interaction loop.
An inhibitor of IFS might be developed to lock the C-terminal
helix in the extended conformation that cannot refold to bind
and inhibit SPN. Consistent with this, bacterial growth is attenu-
ated by overexpression of SPN-IFS, and this effect can be
mitigated by C-terminal truncations of IFS, which include SIL2
and a7b (S. Chandraeskaran and M.G.C., unpublished data).
C-terminal deletionsmay relieve a barrier to conformational rear-
rangement of the C-terminal residues of IFS that enables binding
to SPN. An antibacterial agent that binds to the hydrophobic
surface of IFS serving as the docking site for helices a7a and
a7b might stabilize IFS in an inactive, extended conformation
to unleash the cellular toxicity of SPN, causing depletion of
b-NAD+ within the bacteria and cell death.EXPERIMENTAL PROCEDURES
Construction of SPNct-IFS Expression Plasmid
The SPNct-IFS expression plasmid was constructed from the plasmid pMAM
3.18 (Meehl et al., 2005) in two steps. First, the nucleotides coding the gIIIB
signal sequence, 6XHis and SPN residues 38–190, were removed from this
plasmid to create an intermediate plasmid pJOY114 using an inside-out PCR
strategy and two 50 phosphorylated primers (oJOY187: /5Phos/CAT CAT CAT
ACT TTT GGC AAT ATG GAA CGC GAT CTT TTT GAA AAA AAG TTT AAA G,
and oJOY155: /5Phos/ATG ATG ATG CAT GGT TAA TTC CTC CTG TTA GCC
CAA AAA ACG GGT ATG GAG AAA CAG). Then, nucleotides for two stop
codons (underlined in the primer sequence below) were introduced in
pJOY114 between the coding sequences of the final IFS residue (Phe 161)
and its carboxy-terminal c-mycepitope tagusing theQuikChangeSite-Directed
Mutagenesis Kit (Stratagene) and two complementary primers (IFS stopF: GCT
TGA TATGGTCGAAAGAACAATAGAAACATT TTAGTGAAGCTT TCTAGA
ACA AAA ACT CAT CTC AGA AGA GG, and IFS StopR). The final plasmid
pJOY126 expresses SPNct (Met–6XHis–SPN Thr191–Lys451) and full-length
IFS (residues 1–161) from an L-arabinose-inducible araBAD promoter, and
these proteins form theSPNct-IFS complex in the cytoplasmof theE. coli hosts.200 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All rPurification and Crystallization of SPNct-IFS Complex
The SPNct protein representing the C-terminal glycohydrolase domain of SPN
(residues 191–451) and full-length IFS (residues 1–161) were coexpressed in
E. coli DL41 (methionine auxotroph) using the plasmid pJOY126 as described
previously (Ghosh and Caparon, 2006; Meehl and Caparon, 2004). Cells were
grown in a medium consisting of Luria broth and Bovine Heart Infusion broth
with 100 mg/ml of ampicillin at 37C. When the culture reached an OD600nm
of 2.5, expression was induced by the addition of 0.2% arabinose, and growth
continued for an additional 1–1.5 hr, at which time cells were harvested by
centrifugation and immediately processed, or the pellets were stored at
20C. For expression of selenomethionine protein, cells were grown in M9
media supplemented with all 20 amino acids except methionine, which was
replaced in selenomethionine. For processing, cells were resuspended in
phosphate-buffered saline (PBS) (pH 7.4) and protease inhibitor cocktail
(Sigma Aldrich), then lysed by sonication while chilled on ice, and the cellular
debris was removed by centrifugation at 20,000 3 g for 20 min. The resulting
lysate was subjected to metal-affinity chromatography using a TALON Super-
flow column (Clontech). The SPNct-IFS complex was eluted using a step
gradient of PBS supplemented with 0.3 M imidazole. Fractions containing
the complex were pooled and dialyzed three times for 2 hr each against
20 mM Tris (pH 8.0) at 4C and then subjected to ion-exchange chromatog-
raphy using Q Sepharose FF (GE Healthcare) eluted with a step gradient of
20 mM Tris (pH 8.0) and 0.5 M NaCl. Fractions containing the complex were
pooled, concentrated, and subjected to a size-exclusion chromatography
over a S-200 column (GE Healthcare). Fractions were analyzed for purity by
SDS-PAGE, pooled, dialyzed against 20 mM Tris (pH 8.0), 50 mM NaCl,
0.1 mM EDTA, and stored at 4C. For crystallization, drops containing 1 ml of
15–20 mg/ml of protein and 1 ml of precipitant containing 20%–25% PEG 8K
and 100 mM Tris-HCl (pH 8.0) were equilibrated against the same precipitant
by vapor diffusion at 22C. Crystals appeared in 1–2 days and grew to full size
in 3–5 days. Crystals were in space group C2 with cell dimensions a = 198.42,
b = 57.81, and c = 89.52; b = 107.14 with two molecules per asymmetric unit.
Structure Determination of SPNct-IFS Complex
Before data collection, crystals in stabilizing solution (25% PEG 8K and Tris-
HCl [pH 8.0]) were transferred to the same solution containing 20% glycerol
for 3–5 min and frozen with cold nitrogen gas from an X-Stream system
(Rigaku). X-ray diffraction data were collected at Lawrence Berkeley Labora-
tory beamline 4.2.2 (Molecular Biology Consortium). Images were indexed,
integrated, and scaled using D*TREK (Pflugrath, 1999). Initial phases were
calculated from a three-wavelength (peak, inflection, and low remote) seleno-
methionine MAD experiment. Structure factor calculation and scaling between
sets were done using the CCP4 suite (CCP4, 1994). Of the 28 expected sele-
nium sites, 19 of the strongest sites were located using SHELXD (Schneider
and Sheldrick, 2002), and AutoSHARP (Vonrhein et al., 2007) was used to
locate an additional eight sites, refine the selenium sites, and calculate initial
phases. Maps were improved by density modification using DM (Cowtan
and Main, 1998). Maps were interpretable because we were able to quickly
locate the helical head structure of IFS. The atomic model was built using
COOT (Emsley and Cowtan, 2004). Initial refinement was done by simulated
annealing protocols in CNS (Brunger et al., 1998). The model was further
refined using REFMAC, which included TLS refinement (Murshudov et al.,
1997). Ramachandran analysis showed that 93.6% of the main chain dihedral
angles are in the most favorable regions, 6.27 in additional regions, and 0.12%
in disallowed regions. The final model includes SPNct (residues 196–445) and
the entire IFS molecule (residues 1–161). Residues 191–195 and 446–451 of
SPNct were not seen in the electron density map and assumed to be disor-
dered. Figures were produced using PyMOL (DeLano, 2002).
Purification and Crystallization of IFS
IFS alone with a carboxy-terminal c-myc- and 6XHis-tag was expressed from
the plasmid pMAM 3.19 (Meehl et al., 2005) in E. coli DL41 under the same
culture conditions described above. When the OD600nm reached 3.0, expres-
sion was induced with 0.2% arabinose, and cells were harvested following
an hour of additional growth. Selenomethionine-incorporated protein was
expressed as described for the SPNct-IFS complex. Lysates were prepared
and subjected to metal-affinity chromatography as described above.
Collected fractions were dialyzed three times against 20 mM Tris (pH 8.0),ights reserved
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Structure of S. pyogenes IFS and SPNthen subjected to a Source 15Q column eluted with a salt gradient (0–0.5 M) in
20 mM Tris (pH 8.0), and fractions were analyzed by SDS-PAGE. Fractions
containing greater than 95% IFS were pooled, dialyzed against 20 mM Tris
(pH 8.0), 50 mM NaCl, and concentrated to 12.8 mg/ml. Crystals were grown
using the vapor diffusion method with hanging drops composed of 2 ml of IFS
mixed with 2 ml of precipitant solution containing 1.6–2.0 M ammonium sulfate
and Tris (pH 8.0) then equilibrated over the same precipitant solution. Crystals
were of space group P3121 with cell dimensions a = 108.03 A˚ and c = 147.05 A˚
with four molecules per asymmetric unit.Structure Determination and Refinement of IFS
Prior to freezing, the crystals were transferred from a stabilizing solution
containing 2.5 M ammonium sulfate and 20 mM Tris (pH 8.0), and the same
solution was supplemented with 15% glycerol and frozen with cold nitrogen
gas as described above. X-ray diffraction data were collected at Lawrence
Berkeley Laboratory beamline 4.2.2 (Molecular Biology Consortium). Diffrac-
tion data were indexed, integrated, and scaled using D*TREK (Pflugrath,
1999). Initial phases were calculated from a three-wavelength (peak, inflection,
and low remote) selenomethionine MAD experiment. The structure factor
calculation and scaling between sets were done using the CCP4 suite
(CCP4, 1994). Sixteen of the strongest selenium sites (of the expected 28)
were located from the data set collected at the peak wavelength using
SHELXD (Schneider and Sheldrick, 2002). AutoSHARP (Vonrhein et al.,
2007) was used to locate an additional ten sites, refine the selenium sites,
and calculate initial phases. Maps were improved by density modification
using DM (Cowtan and Main, 1998) and allowed for unambiguous tracing of
the electron density. The atomic model was built using O (Jones et al.,
1991). The initial model was subjected to refinement using CNS (Brunger
et al., 1998) and further refined using REFMAC (Murshudov et al., 1997). Inter-
estingly, two molecules include electron density for the entire IFS (1–161) plus
a portion of the c-myc tag (B: 1–173; C: 1–166), and the other molecules were
truncated (A: 1–155; D: 1–159). Thus, residues 156–161 inmolecule A and resi-
dues 160–161 in molecule D were not seen in electron density and were
assumed to be disordered.ACCESSION NUMBERS
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